Matches in SemOpenAlex for { <https://semopenalex.org/work/W1963936757> ?p ?o ?g. }
- W1963936757 endingPage "46" @default.
- W1963936757 startingPage "35" @default.
- W1963936757 abstract "Several studies suggested an association between the regular use of β2-agonists and asthma deaths. Whether this association represents adverse effects of β -agonist use or is entirely due to disease severity is a matter of ongoing debate. Previous literature indicates that confounding by poor asthma control may explain the apparent deleterious effects of inhaled β2-agonists. Tolerance to nonbronchodilator effects of β2-agonists may account for the increase in reactivity to indirect bronchoconstrictor challenges and explain why some studies have demonstrated enhanced bronchoconstriction in patients with asthma after regular β 2-agonist therapy. Nonetheless, the salmeterol multi-centre asthma research trial (SMART) found more asthma deaths (13 vs 3) and life-threatening asthma events (37 vs 22) in the salmeterol-treated asthmatic patients, although it was documented that among African-Americans, 5 times as many deaths and near-deaths from asthma occurred in those given salmeterol than in those given placebo, and among patients with asthma not using an inhaled corticosteroid (ICS) as a preventive (controller) medication, again more deaths and near-deaths from asthma occurred in those given salmeterol than in those given placebo. Only 38% of the African-Americans who participated in the study used an ICS. As a result of the findings from the SMART, FDA issued a public health advisory to highlight that long-acting β2-agonists (LABAs) should not be the first medicine used to treat asthma. LABAs should be added to the asthma treatment plan only if other medicines, including the use of low-or-medium dose ICSs, do not control asthma. However, despite all of the concerns raised by the SMART, inhaled β2-agonists remain the most effective bronchodilators available for the immediate relief of asthma symptoms and, as such, remain an important component of asthma management. Obviously, there are concerns about LABA treatment as monotherapy for asthma. Patients with asthma should be initiated and maintained on sufficiently high doses of ICSs and only patients whose asthma cannot be controlled should receive additional LABAs on a regular basis." @default.
- W1963936757 created "2016-06-24" @default.
- W1963936757 creator A5060089859 @default.
- W1963936757 creator A5062907116 @default.
- W1963936757 date "2007-10-01" @default.
- W1963936757 modified "2023-09-26" @default.
- W1963936757 title "Review: Safety of long-acting β2 -agonists in the treatment of asthma" @default.
- W1963936757 cites W1795103282 @default.
- W1963936757 cites W1963804030 @default.
- W1963936757 cites W1966364214 @default.
- W1963936757 cites W1971992402 @default.
- W1963936757 cites W1972073156 @default.
- W1963936757 cites W1975380706 @default.
- W1963936757 cites W1976282279 @default.
- W1963936757 cites W1988838297 @default.
- W1963936757 cites W1990651138 @default.
- W1963936757 cites W1990951259 @default.
- W1963936757 cites W1991968623 @default.
- W1963936757 cites W1994745317 @default.
- W1963936757 cites W1996454140 @default.
- W1963936757 cites W2002909192 @default.
- W1963936757 cites W2003038100 @default.
- W1963936757 cites W2004355551 @default.
- W1963936757 cites W2008639514 @default.
- W1963936757 cites W2019855265 @default.
- W1963936757 cites W2019933043 @default.
- W1963936757 cites W2024957042 @default.
- W1963936757 cites W2026731374 @default.
- W1963936757 cites W2026908680 @default.
- W1963936757 cites W2034894452 @default.
- W1963936757 cites W2038693046 @default.
- W1963936757 cites W2057383070 @default.
- W1963936757 cites W2060099663 @default.
- W1963936757 cites W2066043730 @default.
- W1963936757 cites W2066568252 @default.
- W1963936757 cites W2073710619 @default.
- W1963936757 cites W2080196174 @default.
- W1963936757 cites W2084920980 @default.
- W1963936757 cites W2085653196 @default.
- W1963936757 cites W2087457526 @default.
- W1963936757 cites W2087666617 @default.
- W1963936757 cites W2087810578 @default.
- W1963936757 cites W2092016399 @default.
- W1963936757 cites W2098633046 @default.
- W1963936757 cites W2110658984 @default.
- W1963936757 cites W2111537615 @default.
- W1963936757 cites W2113096218 @default.
- W1963936757 cites W2126233278 @default.
- W1963936757 cites W2134436842 @default.
- W1963936757 cites W2148583736 @default.
- W1963936757 cites W2152342181 @default.
- W1963936757 cites W2152785448 @default.
- W1963936757 cites W2153236387 @default.
- W1963936757 cites W2155589243 @default.
- W1963936757 cites W2161036151 @default.
- W1963936757 cites W2161150847 @default.
- W1963936757 cites W2163441905 @default.
- W1963936757 cites W2322498581 @default.
- W1963936757 cites W2322515447 @default.
- W1963936757 cites W2331287401 @default.
- W1963936757 cites W2334701948 @default.
- W1963936757 cites W4241883193 @default.
- W1963936757 cites W45522490 @default.
- W1963936757 cites W51793689 @default.
- W1963936757 doi "https://doi.org/10.1177/1753465807081747" @default.
- W1963936757 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19124346" @default.
- W1963936757 hasPublicationYear "2007" @default.
- W1963936757 type Work @default.
- W1963936757 sameAs 1963936757 @default.
- W1963936757 citedByCount "23" @default.
- W1963936757 countsByYear W19639367572012 @default.
- W1963936757 countsByYear W19639367572013 @default.
- W1963936757 countsByYear W19639367572015 @default.
- W1963936757 countsByYear W19639367572016 @default.
- W1963936757 countsByYear W19639367572017 @default.
- W1963936757 countsByYear W19639367572018 @default.
- W1963936757 countsByYear W19639367572019 @default.
- W1963936757 countsByYear W19639367572021 @default.
- W1963936757 crossrefType "journal-article" @default.
- W1963936757 hasAuthorship W1963936757A5060089859 @default.
- W1963936757 hasAuthorship W1963936757A5062907116 @default.
- W1963936757 hasConcept C126322002 @default.
- W1963936757 hasConcept C142724271 @default.
- W1963936757 hasConcept C177713679 @default.
- W1963936757 hasConcept C197934379 @default.
- W1963936757 hasConcept C204787440 @default.
- W1963936757 hasConcept C27081682 @default.
- W1963936757 hasConcept C2776042228 @default.
- W1963936757 hasConcept C2776136866 @default.
- W1963936757 hasConcept C2776719499 @default.
- W1963936757 hasConcept C2779871671 @default.
- W1963936757 hasConcept C2780769369 @default.
- W1963936757 hasConcept C2781018748 @default.
- W1963936757 hasConcept C42219234 @default.
- W1963936757 hasConcept C71924100 @default.
- W1963936757 hasConcept C77350462 @default.
- W1963936757 hasConceptScore W1963936757C126322002 @default.
- W1963936757 hasConceptScore W1963936757C142724271 @default.